(Q35818751)

10 August 2017

Penetration of foscarnet into cerebrospinal fluid of AIDS patients (English)

1 reference

10 August 2017

0 references

Raffi F

1

1 reference

10 August 2017

Taburet AM

2

1 reference

10 August 2017

Ghaleh B

3

1 reference

10 August 2017

Huart A

4

1 reference

10 August 2017

Singlas E

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

37

1 reference

10 August 2017

9

1 reference

10 August 2017

1777-1780

1 reference

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Antiviral effects of phosphonoformate (PFA, foscarnet sodium).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Inhibition of HTLV-III/LAV replication by foscarnet

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Clinical pharmacology: foscarnet

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188069

Reversible inhibition of cytomegalovirus replication by phosphonoformate

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8239583

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8239583

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.37.9.1777

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

8239583

1 reference